Microscopic Colitis Clinical Trial
Official title:
Risk Factors for Microscopic Colitis: A Dutch Case-Control Study
The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.
Status | Completed |
Enrollment | 487 |
Est. completion date | July 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Confirmed Diagnosis of MC (CC or LC) between January 1, 2000 and December 31, 2012. - Inhabitant of the province of Limburg or the Eindhoven region at the moment of diagnosis Exclusion Criteria: - Below 18 years of age at the time of diagnosis - Not capable of signing an informed consent - Deceased at moment of approximation |
Observational Model: Case Control, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht UMC | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of environmental and hygiene-related risk factors for microscopic colitis | Information about environmental and hygiene-related risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012 | Retrospective, between 2000 and 2012 | No |
Secondary | The difference between the CC and LC subpopulation regarding environmental, hygiene-related, and generally known risk factors | As generally known risk factors are considered: age, gender, medication, comorbidities and smoking. Information about risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012. |
Retrospective between 2000 and 2012 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05998174 -
Faecal Microbiota Transplantation for Microscopic Colitis
|
Early Phase 1 | |
Recruiting |
NCT05058131 -
Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre
|
N/A | |
Completed |
NCT02303132 -
Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis
|
N/A | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Recruiting |
NCT06031064 -
External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea
|
||
Recruiting |
NCT04043897 -
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
|
Phase 2 | |
Recruiting |
NCT06172647 -
Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer
|
||
Recruiting |
NCT03477032 -
FMT in Inflammatory Bowel Disease
|
||
Completed |
NCT03275467 -
Faecal Microbiota Transplantation in Patients With Microscopic Colitis
|
N/A | |
Completed |
NCT00180050 -
Budesonide Treatment for Lymphocytic Colitis
|
Phase 3 | |
Not yet recruiting |
NCT05915104 -
Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis
|
Phase 2 | |
Completed |
NCT00952952 -
Trial of Mesalamine for the Treatment of Active Microscopic Colitis
|
Phase 2/Phase 3 |